HCA Healthcare (NYSE:HCA) Given New $435.00 Price Target at KeyCorp

HCA Healthcare (NYSE:HCA) had its target price cut by KeyCorp from $475.00 to $435.00 in a research report report published on Monday morning, MarketBeat reports. They currently have an overweight rating on the stock.

Several other analysts have also recently weighed in on HCA. Jefferies Financial Group set a $450.00 price objective on HCA Healthcare in a research report on Tuesday, July 14th. Argus dropped their price target on HCA Healthcare from $560.00 to $500.00 and set a “buy” rating on the stock in a research report on Monday, May 4th. Weiss Ratings downgraded HCA Healthcare from a “buy (b-)” rating to a “hold (c+)” rating in a report on Tuesday, June 9th. Royal Bank Of Canada reduced their target price on shares of HCA Healthcare from $534.00 to $435.00 and set an “outperform” rating on the stock in a research report on Wednesday, July 15th. Finally, Wall Street Zen cut shares of HCA Healthcare from a “buy” rating to a “hold” rating in a research report on Saturday, May 2nd. Fourteen equities research analysts have rated the stock with a Buy rating, eight have given a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $473.36.

HCA Healthcare Stock Up 2.0%

NYSE:HCA opened at $389.74 on Monday. The firm’s fifty day simple moving average is $386.30 and its 200 day simple moving average is $452.90. HCA Healthcare has a twelve month low of $331.61 and a twelve month high of $556.52. The stock has a market cap of $86.46 billion, a P/E ratio of 13.05, a price-to-earnings-growth ratio of 1.29 and a beta of 1.12.

HCA Healthcare (NYSE:HCA) last announced its earnings results on Friday, July 24th. The company reported $7.59 earnings per share for the quarter, beating analysts’ consensus estimates of $7.56 by $0.03. HCA Healthcare had a net margin of 8.77% and a negative return on equity of 244.79%. The firm had revenue of $20.23 billion for the quarter, compared to analyst estimates of $19.76 billion. During the same quarter in the previous year, the firm posted $6.84 EPS. The company’s revenue for the quarter was up 8.7% compared to the same quarter last year. On average, analysts expect that HCA Healthcare will post 29.19 EPS for the current fiscal year.

HCA Healthcare Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Wednesday, September 30th. Stockholders of record on Wednesday, September 16th will be given a $0.78 dividend. This represents a $3.12 annualized dividend and a dividend yield of 0.8%. The ex-dividend date of this dividend is Wednesday, September 16th. HCA Healthcare’s payout ratio is currently 10.45%.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently made changes to their positions in HCA. Norges Bank purchased a new stake in shares of HCA Healthcare during the fourth quarter valued at approximately $1,262,513,000. Life Cycle Investment Partners Ltd purchased a new stake in HCA Healthcare during the 4th quarter valued at $374,037,000. Viking Global Investors LP increased its holdings in shares of HCA Healthcare by 58.5% in the 2nd quarter. Viking Global Investors LP now owns 1,872,133 shares of the company’s stock worth $717,214,000 after purchasing an additional 690,773 shares in the last quarter. Northwestern Mutual Wealth Management Co. lifted its holdings in shares of HCA Healthcare by 4,545.5% during the fourth quarter. Northwestern Mutual Wealth Management Co. now owns 663,337 shares of the company’s stock valued at $309,686,000 after purchasing an additional 649,058 shares in the last quarter. Finally, Healthcare of Ontario Pension Plan Trust Fund increased its holdings in HCA Healthcare by 5,941.1% in the 1st quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 381,433 shares of the company’s stock worth $180,509,000 after buying an additional 375,119 shares in the last quarter. Institutional investors own 62.73% of the company’s stock.

Key Headlines Impacting HCA Healthcare

Here are the key news stories impacting HCA Healthcare this week:

• Positive Sentiment: Q2 results exceeded expectations. HCA reported adjusted earnings of $7.59 per share versus the $7.56 consensus estimate, while revenue rose 8.7% year over year to $20.23 billion, topping forecasts of $19.76 billion. The earnings beat and continued revenue growth are supporting investor sentiment. HCA Healthcare’s Q2 CY2026 sales top estimates
• Positive Sentiment: Analysts remain broadly constructive despite lower targets. Truist, Oppenheimer and KeyCorp cut their price targets but retained buy, outperform or overweight ratings. RBC also reaffirmed its outperform rating with a $435 target, indicating that analysts still see upside from current levels. HCA Healthcare Analysts Slash Their Forecasts After Q2 Results
• Neutral Sentiment: HCA declared a quarterly dividend of $0.78 per share. The dividend is payable September 30 to shareholders of record September 16 and carries an indicated yield of approximately 0.8%, providing modest shareholder income.
• Neutral Sentiment: Leadership change at two Tampa hospitals. HCA promoted a new chief executive officer for the facilities, a routine management update with limited immediate financial impact. HCA promotes new CEO of 2 Tampa hospitals
• Negative Sentiment: Uninsured Affordable Care Act patients are a concern. Nearly all of HCA’s ACA exchange patients reportedly lacked insurance coverage during the quarter, highlighting reimbursement and bad-debt risks that could weigh on margins and future earnings.
• Negative Sentiment: Multiple analysts reduced their forecasts after the earnings release. Barclays moved to equal weight with a $387 target, while Baird maintained a neutral rating and lowered its target to $393. The widespread target reductions suggest expectations for HCA’s future growth and profitability have moderated.
• Negative Sentiment: Mission Health compliance concerns remain unresolved. Reports of a third consecutive year of compliance issues add legal, regulatory and reputational risk for HCA. HCA Healthcare faces third straight year of Mission Health compliance concerns

HCA Healthcare Company Profile

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.